CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapy

CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapy

Abstract Background Anamorelin is expected to improve cancer cachexia by increasing lean body mass (LBM) due to increased appetite and protein synthesis. However, the effect of anamorelin on cancer cachexia in real-world practice is unclear. The purpose of this study was to evaluate the efficacy and...

Full description

Bibliographic Details
Main Authors: Hironori Fujii, Akitaka Makiyama, Kayoko Nishimura, Hirotoshi Iihara, Chiemi Hirose, Koichi Ohata, Yunami Yamada, Daichi Watanabe, Itaru Yasufuku, Naoki Okumura, Yoshihiro Tanaka, Takao Takahashi, Ryo Kobayashi, Nobuhisa Matsuhashi, Akio Suzuki
Format: Article
Language:English
Published: BMC 2024-07-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
Cancer cachexia
Anamorelin
CONUT score
Survival
Performance status
Online Access:https://doi.org/10.1186/s40780-024-00359-5

Internet

https://doi.org/10.1186/s40780-024-00359-5

Similar Items